Zhu et al. Journal of Experimental & Clinical Cancer Research 2010, 29:124 http://www.jeccr.com/content/29/1/124 Page 8 of 8 9. Tang HS, Feng YJ, Yao LQ: Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J Gynecol Cancer 2009, 19:605-610. 10. Vaupel P, Mayer A: Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007, 26:225-239. 11. Yao LQ, Feng YJ, Ding JX, Jing HM, Xu CJ, Chen SF, Su M, Yin LH: Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia. Int J Oncol 2007, 30:1069-1075. 12. Su M, Feng YJ, Yao LQ, Cheng MJ, Xu CJ, Huang Y, Zhao YQ, Jiang H: Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer 2008, 18:476-486. 13. Yao LQ, Feng YJ, Ding JX, Xu CJ, Jin HY, Yin LH: [Primary study of vasculogenic mimicry induced by hypoxia in epithelial ovarian carcinoma]. Zhonghua Fu Chan Ke Za Zhi 2005, 40:662-665. 14. Zhu Y, Lin JH, Liao HL, Friedli O Jr, Verna L, Marten NW, Straus DS, Stemerman MB: LDL induces transcription factor activator protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998, 18:473-480. 15. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ: Molecular determinants of ovarian cancer plasticity. Am J Pathol 2001, 158:1279-1288. 16. Hopfl G, Wenger RH, Ziegler U, Stallmach T, Gardelle O, Achermann R, Wergin M, Kaser-Hotz B, Saunders HM, WIlliams KJ, Stratfrod IJ, Gassmann M, Desbaillets I: Rescue of hypoxia-inducible factor-1alpha- deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res 2002, 62:2962-2970. 17. Zhi X, Chen S, Zhou P, Shao Z, Wang L, Ou Z, Yin L: RNA interference of ecto-5’-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin Exp Metastasis 2007, 24:439-448. 18. Weljie AM, Jirik FR: Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect. Int J Biochem Cell Biol 2010. 19. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J, Trent JM, Meltzer PS, Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999, 155:739-752. 20. Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ: Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 2004, 190:899-909. 21. Liu JP, Li H: Telomerase in the ovary. Reproduction 2010, 140:215-222. 22. Ozmen B, Duvan CI, Gumus G, Sonmezer M, Gungor M, Ortac F: The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: a prospective clinical study. Eur J Gynaecol Oncol 2009, 30:303-308. 23. Lubin J, Markowska J, Markowska A, Stanislawiak J, Lukaszewski T: Activity of telomerase in ovarian cancer cells. Clinical implications. Clin Exp Obstet Gynecol 2009, 36:91-96. 24. Xie X, Hsu JL, Choi MG, Xia W, Yamaguchi H, Chen CT, Trinh BQ, Lu Z, Wokf JK, Bast RC Jr, Hung MC: A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. Mol Cancer Ther 2009, 8:2375-2382. 25. Li H, Simpson ER, Liu JP: Oestrogen, telomerase, ovarian ageing and cancer. Clin Exp Pharmacol Physiol 2010, 37:78-82. 26. Spinella F, Rosano L, Del DM, Di C, Nicotra MR, Natali PG, Bagnato A: Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia- inducible factor-1alpha in melanoma cells. PLoS One 2010, 5:e11241. 27. Goteri G, Lucarini G, Zizzi A, Rubini C, Di PR, Tranquilli AL, Ciavattini A: Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts. Virchows Arch 2010, 456:703-710. 28. Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U, Krippl P, Samonigg H, Renner W, Langner C, Dehchamani D, Gerger A: Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog 2010, 49:805-809. 29. Miyazawa M, Yasuda M, Fujita M, Hirabayashi K, Hirasawa T, Kajiwara H, Muranmatsu T, Miyazaki S, Harasawa M, Matsui N, Ogane N, Murakami M, Mikami M, Yanase T, Osamura RY: Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. J Obstet Gynaecol Res 2010, 36:448-453. 30. Villaume K, Blanc M, Gouysse G, Walter T, Couderc C, Nejjari M, Vercherat C, Cordire-Bussat M, Roche C, Scoazec JY: VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/ mTOR pathway. Neuroendocrinology 2010, 91:268-278. 31. Zeng M, Kikuchi H, Pino MS, Chung DC: Hypoxia activates the K-ras proto- oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS One 2010, 5:e10966. doi:10.1186/1756-9966-29-124 Cite this article as: Zhu et al.: The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia. Journal of Experimental & Clinical Cancer Research 2010 29:124. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit